Business Wire

Nojima Partners with GlobalLogic, a Hitachi Group Company, to Accelerate Its Digital Transformation

Share

Nojima Corporation (TSE:7419, "Nojima") today announced a partnership with GlobalLogic Japan, Ltd. (“GlobalLogic Japan”), a Japanese subsidiary of GlobalLogic Inc., acquired by Hitachi, Ltd. (TSE:6501, "Hitachi") in July 2021. The collaboration intends to accelerate the development and implementation of Nojima’s Digital Transformation (“DX”) strategy.

The co-creation program focuses on the deployment of brand-new customer experiences that integrate GlobalLogic’s digital engineering with Nojima’s digitalization initiatives. The program targets accelerating the transformation of Nojima’s brick-and-mortar stores, as well as its unique “consulting-based sales” approach1 for home appliance sales in Japan.

Co-Creation Program Background and Future Roadmap

Nojima holds a corporate-level goal to better contribute to Japan’s domestic industry through the roll out of its digital GS4 strategy (Good, Soft, Support, Service, Setting). To that end, Nojima aims to migrate to a total solution company, leveraging DX to provide new value to customers’ lives in terms of diversity and convenience.

Nojima leverages digital technologies to improve the efficiency of business operations, such as increasing the productivity of services and business processes and establishing high-quality customer service models. Also, the company is proactively generating value through DX in the new domains of digital home appliances and its communication business.

To accelerate its DX strategy, Nojima will leverage GlobalLogic’s vast capabilities and global talent, local presence, and expertise in improving end-customer experiences in the B to C domain. Furthermore, Nojima, GlobalLogic Japan and Hitachi will continue the discussion to evolve the program to provide new customer experiences with better visibility throughout the partnership.

The program will support consolidating Nojima’s DX initiatives to reinforce its "inspiring services." Program objectives may include developing initiatives to improve customer satisfaction, constructing a platform using digital engineering technology, and developing applications that strengthen the connection to end users.

About Nojima Corporation

The Nojima Group aims to migrate to a total solution company in the era of IoT, where all home appliances are connected through the Internet or mobile devices. As a “close consultant,” Nojima provides new values to customers by helping them explore a desired “smart life.”

Given its unique customer service strategy "consulting-based sales," Nojima is the only home appliance specialty store where its own employees recommend products based on the demand of each customer, whereas dispatching a salesperson from manufacturers and carriers is the mainstream in the home appliance sales industry.

Nojima Group currently is operating its digital home appliance specialty stores in the Tokyo metropolitan area, nationwide mobile carrier stores, Internet business, and overseas stores. Nojima has established an organization structure to bring a comfortable lifestyle to the customers by providing a variety of product selection as well as support services, focusing on digital home appliances. To enrich the lives of customers, we, Nojima, as a consultant of your “smart life,” aim to deliver "inspiring services" beyond customers’ expectations. For more information on Nojima, please visit the company's website at https://www.nojima.co.jp.

About Hitachi, Ltd.

Hitachi drives Social Innovation Business, creating a sustainable society with data and technology. We will solve customers' and society's challenges with Lumada solutions leveraging IT, OT (Operational Technology) and products, under the business structure of Digital Systems & Services, Green Energy & Mobility, Connective Industries and Automotive Systems. Driven by green, digital, and innovation, we aim for growth through collaboration with our customers. The company’s consolidated revenues for fiscal year 2021 (ended March 31, 2022) totaled 10,264.6 billion yen ($84,136 million USD), with 853 consolidated subsidiaries and approximately 370,000 employees worldwide. For more information on Hitachi, please visit the company's website at https://www.hitachi.com.

About GlobalLogic

GlobalLogic (www.globallogic.com) is a leader in digital engineering. We help brands across the globe design and build innovative products, platforms, and digital experiences for the modern world. By integrating experience design, complex engineering, and data expertise – we help our clients imagine what’s possible and accelerate their transition into tomorrow’s digital businesses. Headquartered in Silicon Valley, GlobalLogic operates design studios and engineering centers around the world, extending our deep expertise to customers in the automotive, communications, financial services, healthcare and life sciences, manufacturing, media and entertainment, semiconductor, and technology industries. GlobalLogic is a Hitachi Group Company operating under Hitachi, Ltd. (TSE: 6501), which contributes to a sustainable society with a higher quality of life by driving innovation through data and technology as the Social Innovation Business.

GlobalLogic is a trademark of GlobalLogic. All other brands, products or service names are or may be trademarks or service marks of their respective owners.

____________________

1Nojima's unique customer service and sales strategy. In the store, there is no salesperson dispatched by the manufacturers. Instead Nojima’s own employees provide consulting services to customers and recommend products from different manufacturers based on the demand of each customer.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

GlobalLogic Inc. (Global)
Heather Ailara
211 Communications
+1.973.567.6040
heather@211comms.com

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 18:03:00 CEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO ® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 17:43:00 CEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 17:22:00 CEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/Contact information Hawthorn Advisors suzano@hawthornadvisors.com

Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 14:30:00 CEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new

MEDIA ALERT: Wolters Kluwer expert comments on European Parliament vote to pass amendment implementing Basel III reforms26.4.2024 14:00:00 CEST | Press release

The European financial landscape saw a milestone event this week, as the EU Parliament passed the Amendment to Regulation (EU) No 575/2013, implementing the Basel III finalization within Europe. This monumental step forward comes with the adoption of the Capital Requirements Regulation (CRR3) amendments, which are part of a broader legislative package, including amendments to Directive 2013/36/EU, known as the Capital Requirements Directive or CRD. Jeroen Van Doorsselaere, Vice President of Global Product & Platform Management, Wolters Kluwer FRR, said: “The adoption of the Capital Requirements Regulation (CRR3) amendments represents a landmark change for the banking industry, designed to strengthen the framework for risk-based capital requirements and address ESG risks. “This is a major overhaul of the capital requirements framework, impacting various aspects, including credit risk, operational risk, market risk, and the capital floor. Whereas other significant jurisdictions, includin

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye